CHPA Elects Board and Officers at Annual Executive Conference

Washington, D.C. (March 11, 2005)—Board and officers of the Consumer Healthcare Products Association (CHPA) were elected today during the Association’s March 10-12 Annual Executive Conference. Timothy G. Hayes, senior vice president & region head, North America, Bayer HealthCare LLC, was approved for his second year as board chair. Richard K. Green, board member, Blistex Inc., continues his tenure as immediate past chair.

CHPA vice chairs:

  • Mary Lynn Ferguson-McHugh, vice president, Global Personal Health Care, The Procter & Gamble Company;*
  • John T. Hendrickson, executive vice president & general manager, Perrigo Consumer Healthcare, Perrigo Company;*
  • Gordon Knapp, president, Consumer Healthcare North America, Pfizer Inc;
  • Patrick M. Lonergan, partner, president, NUMARK Laboratories;
  • William L. McComb, president, McNeil Consumer & Specialty Pharmaceuticals;
  • George M. Quesnelle, president, North America, Consumer Healthcare, GlaxoSmithKline;* and
  • Douglas A. Rogers, president, U.S. Healthcare Division, Wyeth Consumer Healthcare.

CHPA Board members:

  • Christopher B.  Ascher, executive vice president, B.F. Ascher & Company, Inc.;
  • Gale K. Bensussen, president, Leiner Health Products Inc.;
  • Timothy M. Callahan, president, North America, ACNielsen;*
  • Brad A. Casper, president, Personal Care, Church & Dwight Co., Inc.; 
  • Gary R. Downing, chief executive officer, Lansinoh Laboratories, Inc.;
  • Zan Guerry, chairman of the board & chief executive officer, Chattem, Inc.;
  • Jeffrey S. Himmel, chairman & chief executive officer, Himmel Pharmaceuticals Inc.;
  • Charles J. Hinkaty, chief operating officer, Del Laboratories, Inc.;
  • Daniel R. Johnson, senior vice president, general counsel and secretary, Combe Incorporated;
  • Carl J. Johnson, president & chief executive officer, Matrixx Initiatives, Inc.;*
  • James J. Mackey, senior vice president, Healthcare Products, Schering-Plough HealthCare Products, Inc.;
  • Peter C. Mann, president & chief executive officer, Prestige Brands, Inc.;
  • John McKittrick, New York sales manager/drug category manager, Reader’s Digest;
  • Brian J. McNamara, senior vice president, general manager, OTC North America,  Novartis Consumer Health, Inc.;
  • Jeffrey M. Nugent, president & chief executive officer, Insight Pharmaceuticals Corp.;*
  • Gregory C. Pulido, chairman & chief executive officer, Humco Holding Group, Inc.;
  • Bill Seiden, senior vice president, Marketing & Sales, Taro Pharmaceuticals U.S.A., Inc.;
  • Matthew I. Seiden, chief executive officer, president, The Seiden Group;
  • Michael J. Valentino, president and chief executive officer, Adams Respiratory Therapeutics;
  • Renaat Van den Hooff, worldwide president, Johnson & Johnson • Merck Consumer Pharmaceuticals Co.;
  • Neill B. Walsdorf, Jr., president, Mission Pharmacal Company;
  • Akiyoshi Yoshida, Ph.D., president and chief executive officer, The Mentholatum Company, Inc.;
  • Tyler F. Young, president & chief executive officer, W.F. Young, Inc.;
  • Michael A. Zeher, president, Pharmaceutical Formulations, Inc.; and
  • Ted E. Ziemann, president, Cargill Health & Food Technologies.

Serving on the board ex officio as a committee chair:

  • William E. Hawxhurst, vice president and assistant general counsel, Bayer HealthCare LLC (Government Affairs Committee chair);
  • Edwin L. Hemwall, Ph.D., vice president, Global Regulatory Affairs, Johnson & Johnson • Merck Consumer Pharmaceuticals Co. (Scientific Affairs Committee chair);
  • Richard C. Norgard, director, Global Manufacturing Compliance, Pfizer Inc (Manufacturing Controls Committee chair); and
  • Adam D. Raczkowski, executive vice president, chief operating officer, chief financial officer, and general manager, W.F. Young, Inc. (Business Development Committee chair).

*denotes newly elected to this position

Contacts: Elizabeth Assey and Virginia Cox, 202.429.9260


CHPA is the 124-year-old trade association representing U.S. manufacturers and distributors of over-the-counter medicines and nutritional supplement.